Nat Schuster

Pain and Headache Neurologist

[Nat Schuster @NatSchusterMD]

Presented results of the 1st placebo-controlled study of #cannabis for acute #migraine today at #AHSAM. You can sign up for email updates on our research here: https://t.co/0EPMOz8HAq

[NeurologyLive® @neurology_live]

In a new conversation, Dr. Nathaniel Schuster of @UCSanDiego breaks down trial findings on vaporized cannabis for acute migraine—discussing patient selection, timing, and how results may guide care decisions 🌿📋

🔗https://t.co/Qc2GsvpE4A

[AmaalStarlingMD @AmaalStarlingMD]

Congratulations @NatSchusterMD on your research on cannabis as an acute treatment for #migraine. Great work, fascinating results, and I know this was hard work - congrats! #AHSAM #MigraineWarriors

[Continuum: Lifelong Learning in Neurology @ContinuumAAN]

The long-awaited issue on pain management in neurology, guest edited by Dr. Nathaniel Schuster, publishes on October 2! @NatSchusterMD @meredith_barad @JosephKass4 @PrasadShirvalka @VernWilliamsMD @LyellJ @AANmember #Neurology #NeuroTwitter #MedEd

[Center for Medicinal Cannabis Research (CMCR) @cmcr_ucsd]

UCSD’s @NatSchusterMD will be speaking at the upcoming CMCR symposium on his randomized clinical trial of cannabis for migraine headaches. Registration is open now and is free. https://t.co/urBVq5gGo9 #MedicalCannabis #CannabisEducation

[Nat Schuster @NatSchusterMD]

Data from the first placebo-controlled RCT of vaporized cannabis for acute migraine presented today at #AANAM. @SaitAshina

[medRxiv @medrxivpreprint]

Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial https://t.co/qepI7P0VVy #medRxiv

[Nat Schuster @NatSchusterMD]

At #NANS24? Please join for our facial pain breakfast session tomorrow morning! Also looking forward to presenting new data from our placebo-controlled study of vaporized cannabinoids for acute migraine at #AAPM2024 @AmerAcadPainMed

[Lynn Kohan @KohanLynn]

Thank you @NarouzeMD for highlighting this essential topic. So many headache sufferers need effective tx. We need to close the gap. #headacheSIG @NatSchusterMD

[Neurology Today @NeurologyToday]

Via @HeadacheJournal: Soldiers who had recently been deployed had much lower levels of potential headache and pain biomarkers—the opposite of what researchers expected to find: https://t.co/wmBNgWo8sw

#NeuroTwitter @AANMember @USUhealthsci @NatSchusterMD @petergoadsby

[CoalitionCHAMP @CoalitionCHAMP]

Pregnant? Consider joining the Teva Migraine Pregnancy Registry (CHAMP Sponsor). Your experience with the use of migraine medication during pregnancy could help women and doctors in the future. https://t.co/HWiGQUj3SA

[Nat Schuster @NatSchusterMD]

@Talktoratan @AmyPearsonMD @KohanLynn @NarouzeMD @AmerAcadPainMed @ASIPP @ASRA_Society @ASALifeline @PainMedJournal @BritishPainSoc @CJA_Journal @EMARIANOMD @dr_rajgupta @jonhagedornmd @IARS_Journals @AbaPhysicians @Qadri_YJ @GottumukVijaya https://t.co/SOroXOISYN

[Nat Schuster @NatSchusterMD]

@Talktoratan @AmyPearsonMD @KohanLynn @NarouzeMD @AmerAcadPainMed @ASIPP @ASRA_Society @ASALifeline @PainMedJournal @BritishPainSoc @CJA_Journal @EMARIANOMD @dr_rajgupta @jonhagedornmd @IARS_Journals @AbaPhysicians @Qadri_YJ @GottumukVijaya Iliocostal Friction Syndrome Due to Hair-Pin Shaped Thoracic Kyphosis 2/2 Spinal Tuberculosis (Pott’s disease)- Thanks @Talktoratan for publishing this case with interesting imaging in #TeachingImages in @PainMedJournal

[NeurologyLive® @neurology_live]

At #ASHAM, @NatSchusterMD provided perspective on how #cannabis may be used in the management of migraine as more evidence is uncovered. #neurotwitter

Watch here: https://t.co/2WFAgWsAwK

[Nat Schuster @NatSchusterMD]

Vaporized THC, CBD combination efficacious in migraine treatment https://t.co/mv583paHms @healioneurology @UCSDHealth @UCSDnews @ahsheadache @cynarmandmd @NeurologyToday @AANmember @LyellJ @ASRA_Society @PracticalPain

[Nat Schuster @NatSchusterMD]

@WakeRevolt @MigraineSummit @NinaRiggins @DawnBuse @mrobbinsmd @CGottschalkMD @SengElizabeth @ahsheadache @ihs_official @cynarmandmd @rashmihalker Not yet to my knowledge

[Nat Schuster @NatSchusterMD]

Presenting results of the 1st placebo-controlled study of #cannabis for acute #migraine today at #AHSAM at 9:15am. You can sign up for email updates on our research here: https://t.co/0EPMOz8HAq

[Shravani Durbhakula, MD, MPH, MBA @ShravaniD_MD]

Thrilled to be quoted by @Newsweek on #policy #solutions for treating #pain effectively while reducing #overdoses in this #cover story! @HopkinsMedicine @KohanLynn @SMoeschlerMD @ErikaPetersenMD @DrNatStrand @NarouzeMD @ZackMcCormickMD @AmerAcadPainMed

[Ratan Banik @Talktoratan]

Join @UMNanes #pain interest group meeting on 5/17 at 3:30 pm CST via @Zoom with @NatSchusterMD of @UCSDHealth and @Dr_CherylStucky of @MedicalCollege

#MedTwitter @FutureAnesRes #anesthesiology
@ShravaniD_MD, @mbroach4, @ZackMcCormickMD
@VwaireO
🔗Zoom link - [email protected]

[American Academy of Pain Medicine (AAPM) @AmerAcadPainMed]

Methodological gaps in Traeger et al's Cochrane review invalidate its conclusion that spinal cord stimulation is "probably not effective" for low back pain. AAPM members respond with a commentary: @PainMedJournal

Article: https://t.co/2PvJBT527m
Podcast: https://t.co/9nIZygJinK